Get Real Time Here
| Open- | Close- |
| Vol / Avg.0 / 324.587K | Mkt Cap362.919M |
| Day Range- - - | 52 Wk Range3.810 - 27.920 |
IGM Biosciences Stock (NASDAQ:IGMS), Quotes and News Summary
IGM Biosciences Stock (NASDAQ: IGMS) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 324.587K | Mkt Cap362.919M |
| Day Range- - - | 52 Wk Range3.810 - 27.920 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.220 | -1.040 | 0.1800 | ||||
| REV | 780.000K | 509.000K | -271.000K |
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.430 | -1.430 | 0.0000 | ||||
| REV | 800.000K | 448.000K | -352.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-11-15 | Morgan Stanley | Michael Lapides | Maintains | Equal-WeightEqual-Weight | Lowers | 15.00 | 8.00 |
| 2023-11-15 | HC Wainwright & Co. | Robert Burns | Maintains | BuyBuy | Lowers | 17.00 | 11.00 |
| 2023-11-14 | Stifel | Stephen Willey | Maintains | BuyBuy | Lowers | 26.00 | 25.00 |
| 2023-11-14 | RBC Capital | Brian Abrahams | Maintains | Sector PerformSector Perform | Lowers | 11.00 | 8.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| IGMS | IGM Biosciences | 0% | 362.9M |
| IMNM | Immunome | 0% | 333.3M |
| ORTX | Orchard Therapeutics | -0.56% | 366.9M |
| CELC | Celcuity | -2.55% | 350.9M |
| VYGR | Voyager Therapeutics | 0% | 334.8M |
How do I buy IGM Biosciences (IGMS) stock?
You can purchase shares of IGM Biosciences (NASDAQ: IGMS) through any online brokerage.
Who are IGM Biosciences's (IGMS) competitors?
Other companies in IGM Biosciences’s space includes: Immunome (NASDAQ:IMNM), Orchard Therapeutics (NASDAQ:ORTX), Celcuity (NASDAQ:CELC), Voyager Therapeutics (NASDAQ:VYGR) and Korro Bio (NASDAQ:KRRO).
What is the target price for IGM Biosciences (IGMS) stock?
The latest price target for IGM Biosciences (NASDAQ: IGMS) was reported by Morgan Stanley on Wednesday, November 15, 2023. The analyst firm set a price target for 8.00 expecting IGMS to rise to within 12 months (a possible 28.72% upside). 19 analyst firms have reported ratings in the last year.
Current Stock Price for IGM Biosciences (IGMS)?
The stock price for IGM Biosciences (NASDAQ: IGMS) is $6.215 last updated December 1, 2023 at 9:00 PM UTC.
Does IGM Biosciences (IGMS) pay a dividend?
There is no dividend information for IGM Biosciences.
When is IGM Biosciences (NASDAQ:IGMS) reporting earnings?
IGM Biosciences’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is IGM Biosciences (IGMS) going to split?
There is no upcoming split for IGM Biosciences.
What sector and industry does IGM Biosciences (IGMS) operate in?
IGM Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.